{
    "uniprot_canonical_ac": "A0A1D5PIQ4-1",
    "uniprot_id": [
        {
            "id": "A0A1D5PIQ4_CHICK",
            "url": "https://www.uniprot.org/uniprot/A0A1D5PIQ4_CHICK",
            "type": "external"
        }
    ],
    "mass": 34559.0,
    "length": 334,
    "protein_name": "Homeobox protein engrailed-like",
    "gene_name": "EN1",
    "organism": "Chicken",
    "refseq_name": "homeobox protein engrailed-1",
    "refseq_ac": [
        {
            "id": "NP_001383927",
            "url": "https://www.ncbi.nlm.nih.gov/protein/NP_001383927",
            "type": "external"
        }
    ],
    "gene_names_uniprotkb": "EN1",
    "gene_names_refseq": "EN1; En-1; en-3; Gg-En-1",
    "protein_names_uniprotkb": "Homeobox protein engrailed-like",
    "protein_names_refseq": "homeobox protein en-1; engrailed protein; Engrailed-3; homeobox protein engrailed-1",
    "tax_id": 9031,
    "disease": "",
    "pathway": " (gga:771008)",
    "pathway_count": 1,
    "publication_count": 1,
    "publication_id_list": "28807781",
    "function": "##Evidence-Data-START## Transcript exon combination :: BU201973.1, BU136563.1 [ECO:0000332] RNAseq introns :: single sample supports all introns SAMEA103992290, SAMEA103992393 [ECO:0000348] ##Evidence-Data-END## VALIDATED REFSEQ: This record has undergone validation or preliminary review. The reference sequence was derived from JAENSK010000236.1. On or before Oct 29, 2021 this sequence version replaced XP_001234329.4, XP_040532523.1. Sequence Note: The RefSeq transcript and protein were derived from genomic sequence to make the sequence consistent with the reference genome assembly. The genomic coordinates used for the transcript record were based on alignments., [RefSeq]; Engrailed plays an evolutionarily conserved role in the separate innervation of vertebrate epaxial-hypaxial muscle., [RefSeq, PubMed]",
    "predicted_glycosites": 0,
    "predicted_n_glycosites": 0,
    "predicted_o_glycosites": 0,
    "mined_glycosites": 0,
    "mined_n_glycosites": 0,
    "mined_o_glycosites": 0,
    "reported_n_glycosites": 0,
    "reported_o_glycosites": 0,
    "reported_n_glycosites_with_glycan": 0,
    "reported_o_glycosites_with_glycan": 0,
    "total_reported_n_glycosites": 0,
    "total_reported_o_glycosites": 0,
    "total_n_glycosites": 0,
    "total_o_glycosites": 0,
    "reported_fully_resolved_glycans": 0,
    "reported_phosphosites": 0,
    "reported_mutagensis": 0,
    "reported_glycation": 0,
    "reported_snv": 0,
    "reported_interactions": 0,
    "missing_score": 10000,
    "biomarker_type": "",
    "glycan_count": 0,
    "disease_count": 0,
    "glyco_site_count": 0,
    "binding_glycan_count": 0,
    "secondary_ac_list": "",
    "ec_number_list": [],
    "go_molecular_function": "GO:0001227 DNA-binding transcription repressor activity, RNA polymerase II-specific;GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding;GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific",
    "go_cellular_component": "GO:0005634 nucleus",
    "go_biological_process": "GO:0006357 regulation of transcription by RNA polymerase II;GO:0008344 adult locomotory behavior;GO:0045944 positive regulation of transcription by RNA polymerase II;GO:0035264 multicellular organism growth;GO:0043524 negative regulation of neuron apoptotic process",
    "synthesized_glycan_count": 0,
    "record_id": "A0A1D5PIQ4-1",
    "record_type": "protein",
    "filter_code": "0000000.0000101.100000.0001000000000000.00000.000"
}